NDC 47781-408 – Buprenorphine transdermal system
Buprenorphine 20 ug/h · Patch, Extended Release · Transdermal
Product NDC47781-408
Product details
- Brand name
- Buprenorphine transdermal system
- Generic name
- Buprenorphine
- Labeler
- Alvogen Inc.
- Dosage form
- Patch, Extended Release
- Route
- Transdermal
- Marketing category
- ANDA · ANDA207490
- Marketed since
- May 17, 2022
- Marketing end
- January 31, 2027
- Pharmacologic class
- Partial Opioid Agonist
Active ingredients
- Buprenorphine 20 ug/h
Uses, dosage, side effects and warnings for Buprenorphine transdermal system →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 47781-408-04 | 4 POUCH in 1 CARTON (47781-408-04) / 1 PATCH in 1 POUCH (47781-408-11) / 168 h in 1 PATCH | Aug 29, 2022 |